We observed significantly improved tumor control (Figure 4A) and overall survival (Figure 4B) in mice treated with Alb-Flt3L plus cisplatin compared with Alb-Flt3L alone, cisplatin alone, or untreated controls. This evidence concerns the gene FLT3LG and neoplasm.